Journal article
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
Abstract
BACKGROUND: Antithrombotic therapy with heparin plus aspirin reduces the rate of ischemic events in patients with unstable coronary artery disease. Low-molecular-weight heparin has a more predictable anticoagulant effect than standard unfractionated heparin, is easier to administer, and does not require monitoring.
METHODS: In a double-blind, placebo-controlled study, we randomly assigned 3171 patients with angina at rest or non-Q-wave …
Authors
Cohen M; Demers C; Gurfinkel EP; Turpie AGG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KAA; Premmereur J
Journal
New England Journal of Medicine, Vol. 337, No. 7, pp. 447–452
Publisher
Massachusetts Medical Society
Publication Date
August 14, 1997
DOI
10.1056/nejm199708143370702
ISSN
0028-4793